EU · EudraLex Vol.4
EU GMP Annex 1 10.6
10. Quality Control (QC)
조항 원문
The sterility test should be performed under aseptic conditions. Samples taken for sterility testing should be representative of the whole of the batch but should in particular include samples taken from parts of the batch considered to be most at risk of contamination, for example:
i. For products which have been filled aseptically, samples should include containers filled at the beginning and end of the batch. Additional samples, e.g. taken after critical interventions should be considered based on risk.
ii. For products which have been heat sterilised in their final containers, samples taken should be representative of the worst case locations (e.g. the potentially coolest or slowest to heat part of each load).
iii. For products which have been lyophilized, samples taken from different lyophilization loads.
Note: Where the manufacturing process results in sub-batches (e.g. for terminally sterilised products) then sterility samples from each sub-batch should be taken and a sterility test for each sub-batch performed. Consideration should also be given to performing separate testing for other finished product tests.
본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.
출처: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · 수집일 2026-11-15